secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2026-09-28T20:05:22+00:00
Accession:  0001628280-26-063712
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

SkinHealth stockholders approve reverse split of 1-for-5 to 1-for-20 at September 22 special meeting
--------------------------------------------------------------------------------

- Proposal 1 passed with 114,398,602 votes for, 1,406,150 against and 88,570 abstentions; exact split ratio left to the board's sole discretion within the 1-for-5 to 1-for-20 range.
- Proposal 2, allowing adjournment for further proxy solicitation, passed 114,344,814 for to 1,450,597 against, with 97,911 abstentions.
- 130,140,763 Class A shares outstanding as of the August 3, 2026 record date; 115,893,322 shares (89.05%) present virtually or by proxy, establishing a quorum.
- No broker non-votes were recorded on either proposal; matters were described in the Definitive Proxy Statement on Schedule 14A filed August 12, 2026.
- Filing signed by Michael Monahan, Chief Financial and Operating Officer, dated September 28, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026063712/0001628280-26-063712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026063712/skin-20260922.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-063712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer